Readmissions After Cardiac Surgical Procedures

Cardiac Surgery Clinical Trial

Official title:

Readmissions After Cardiac Surgical Procedures

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05225246
• Other study ID #: 2020-02023; kt22Reuthebuch
• Status: Completed
• Start date: September 1, 2020
• Est. completion date: December 31, 2021

Study information

• Verified date: January 2022
• Source: University Hospital, Basel, Switzerland
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is to analyze the reasons for unplanned readmissions after cardiac surgery at the University Hospital Basel. Predictive factors for readmissions and the development over the last 10 years will be analyzed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4882
• Est. completion date: December 31, 2021
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria for readmission group:

• Patients who had heart surgery and returned unplanned to the University Hospital Basel within 30 days of leaving the hospital (outpatient or inpatient)

Inclusion Criteria for control group:

• Patients who had heart surgery and did not return unplanned to the University Hospital Basel within 30 days of leaving the hospital (outpatient or inpatient)

Exclusion Criteria:

• Patients with other initial hospitalization reasons for heart surgery without heart surgery (conservative treatments, cerclage removal, pacemaker surgery) are not included in the analysis.

• Planned readmissions to the University Hospital Basel within 30 days

Related Conditions & MeSH terms

• Cardiac Surgery

Intervention

Other:
• Data collection on reasons for unplanned readmission to the University Hospital Basel within 30 days of leaving the hospital
Descriptive analysis of the reasons for unplanned readmissions after cardiac surgery and predictive factors for unplanned readmissions and validation of risk scores

Locations

Country	Name	City	State
Switzerland	University Hospital Basel, Cardiac Surgery Clinic	Basel

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of cardiac related readmissions compared to infections, bleedings and neurological causes	Number of cardiac related readmissions compared to infections, bleedings and neurological causes	one time assessment at baseline
Primary	Sex specific reasons for readmissions	Differences in sex specific reasons for readmissions	one time assessment at baseline